PROMISE I is a multi-center, prospective, single-arm study conducted at seven U.S. centers encompassing end-stage — or “no option” — CLTI patients. All patients were confirmed as “No-Option” and facing imminent amputation by an independent review committee of vascular surgeons. Patients were enrolled between July 2017 and April 2019.
Patient Demographics
32 Patients
12-Month Outcomes1
N=31
Freedom from Amputation
Amputation-free survival
Survival
Technical success